172 related articles for article (PubMed ID: 37259027)
21. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
22. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
23. Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis.
Cheng H; Huo L; Wang D; Xiang Y
J Gynecol Oncol; 2019 Nov; 30(6):e99. PubMed ID: 31576691
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Liu S; He L; Sheng C; Su R; Wu X; Sun Y; Xi X
Biomed Res Int; 2021; 2021():6622439. PubMed ID: 34124253
[TBL] [Abstract][Full Text] [Related]
25. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract][Full Text] [Related]
26. NDC80 Kinetochore Complex Serves as a Potential Prognostic Predictor and Correlates with Immune Infiltrates in Epithelial Ovarian Cancer Patients.
Yu X; Pan M; Jiang L; Liu K
Int J Gen Med; 2024; 17():1789-1805. PubMed ID: 38711823
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
Wu Y; Huang B; Liu Q; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
[TBL] [Abstract][Full Text] [Related]
28. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
[TBL] [Abstract][Full Text] [Related]
29. Development of a five-gene signature as a novel prognostic marker in ovarian cancer.
Wang R; Ye XH; Zhao XL; Liu JL; Zhang CY
Neoplasma; 2019 May; 66(3):343-349. PubMed ID: 30569721
[TBL] [Abstract][Full Text] [Related]
30. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
31. Effects of Autophagy-Related Genes on the Prognosis and Immune Microenvironment of Ovarian Cancer.
Zhang J; Yan H; Fu Y
Biomed Res Int; 2022; 2022():6609195. PubMed ID: 35941978
[TBL] [Abstract][Full Text] [Related]
32. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
[TBL] [Abstract][Full Text] [Related]
33. High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.
Wang J; Cui S; Zhang X; Wu Y; Tang H
PLoS One; 2013; 8(4):e62876. PubMed ID: 23638161
[TBL] [Abstract][Full Text] [Related]
34. Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer.
Liu L; Wang Q; Zhou JY; Zhang B
J Ovarian Res; 2023 Apr; 16(1):88. PubMed ID: 37122030
[TBL] [Abstract][Full Text] [Related]
35. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
[TBL] [Abstract][Full Text] [Related]
36. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
[TBL] [Abstract][Full Text] [Related]
38. Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients.
Bairi KE; Trapani D; Page CL; Saad A; Jarroudi OA; Afqir S
Cancer Treat Res Commun; 2022; 33():100625. PubMed ID: 36057142
[TBL] [Abstract][Full Text] [Related]
39. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of
Qi B; Liu S; Liu D; Yao H; Yan R
Dis Markers; 2022; 2022():2687867. PubMed ID: 35140819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
